668 postmenopausal HR-positive and HER2-negative ABC patients who had not received prior treatment were randomized 1:1 to receive ribociclib plus letrozole or placebo plus letrozole 68. The gene discussed is ERBB2; the disease is aneurysmal bone cyst.